MICREGEN LTD is a biotechnology startup with the slogan "…for a healthier world." Founded in 2015, the company aims to increase healthspan and prolong the period of quality active life. Micregen focuses on addressing the challenges posed by an increasingly aging population suffering from multimorbidity, thereby putting pressure on healthcare systems worldwide. The company's innovative approach involves the development of the Secretomix® platform, which aims to produce various secretome formulations for different diseases. Through a unique understanding of how stem cells can be manipulated to produce optimized stem cell secretions, Micregen explores the effects of its products on various disease states, with the target of extending the period of living healthily. Micregen's Stem cell secretomes have been proven to stimulate tissue repair, modulate inflammation and scarring, improve blood flow, and generate a pro-regenerative microenvironment across various organs and tissue types. The company believes that its approach could change how multiple critical and chronic problems are managed, addressing not just the symptoms but the root causes of diseases. With a focus on biotechnology, health and wellness, and life sciences, Micregen's Secretomix® platform offers the potential to deliver substantial economic improvement for global health services while providing significant benefits to humanity. The company's founders bring lifetime experience in the use of autologous stem cell secretome therapeutics, which has already improved lives and saved world-famous sporting careers.
There is no investment information
No recent news or press coverage available for MICREGEN LTD.